Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Banco Macro S.A. ADR (NY: BMA )

47.60 -4.03 (-7.80%)
Streaming Delayed Price Updated: 3:06 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Banco Macro S.A. ADR

< Previous 1 2 Next >
Exploring growth characteristics of BANCO MACRO SA-ADR (NYSE:BMA).
Why BANCO MACRO SA-ADR (NYSE:BMA) qualifies as a high growth stock. 
Via Chartmill
Why the growth investor may take a look at NYSE:BMA.
BANCO MACRO SA-ADR (NYSE:BMA) is a candidate for growth investors. Here's why. 
Via Chartmill
Why the growth investor may take a look at BANCO MACRO SA-ADR (NYSE:BMA).
Evaluating BANCO MACRO SA-ADR (NYSE:BMA) for Growth Investment Opportunities. 
Via Chartmill
BMA Stock Earnings: Banco Macro Reported Results for Q1 2024
Banco Macro just reported results for the first quarter of 2024. 
Via InvestorPlace
2 Stocks That Could Keep Soaring After Crushing Earnings Expectations
The substantial increase on their bottom lines is reason to believe earnings estimate revisions could trend higher for Deckers Outdoor and Macro Bank in the following weeks. 
Via Talk Markets
Evaluating NYSE:BMA for Growth Investment Opportunities.
Why the growth investor may take a look at BANCO MACRO SA-ADR (NYSE:BMA). 
Via Chartmill
Elon Musk Endorses Argentine Stocks; Bond, ETF Rally Persists In Wake Of Milei's Election Victory
Elon Musk recommends investing in Argentina and assets soar: ETF up 54%; bank stocks up over 100%; IMF praises stabilization efforts. 
Via Benzinga
Topics ETFs
Why NYSE:BMA is Poised for High Growth.
Why the growth investor may take a look at BANCO MACRO SA-ADR (NYSE:BMA). 
Via Chartmill
High growth, ROE and relative strength for NYSE:BMA, growth investors may appreciate this.
Exploring growth characteristics of BANCO MACRO SA-ADR (NYSE:BMA). 
Via Chartmill
BMA Stock Earnings: Banco Macro Beats EPS for Q2 2023
BMA stock results show that Banco Macro beat analyst estimates for earnings per share the second quarter of 2023. 
Via InvestorPlace
Unlocking the Growth Potential of NYSE:BMA.
Is BANCO MACRO SA-ADR (NYSE:BMA) a Fit for Growth Investing Strategies? 
Via Chartmill
Argentine Stocks Rebound As President Milei Eyes Potential New IMF Deal, Exit From Capital Controls
Argentine stocks surge on rumors of a new IMF program to secure funding and lift capital controls, with President Milei aiming for mid-year reforms. 
Via Benzinga
Preview: Banco Macro's Earnings
Via Benzinga
Argentina's Inflation Was Around 200% in 2023 — And It Could Get Worse in 2024: New Leadership Says It Will Take Time To Reverse
Argentina’s inflation rate was around 200% in 2023, according to Reuters. 
Via Benzinga
Topics Economy
Exposures Interest Rates
YPF Sociedad And Other Argentine Stocks Are Moving Today: What's Happening?
Last week, U.S.-listed Argentine stocks rose on news of the election of far-right libertarian candidate, Javier Milei, who campaigned on economic policies which represent a large shift from the current... 
Via Benzinga
Banco Macro: Dividend Insights
Tuesday marks the last chance for investors to receive the next dividend payout from Banco Macro (NYSE:BMA). 
Via Benzinga
Why Stocks in Argentina Are Flying Today
Argentine banking stocks are expensive, and getting more so by the day. 
Via The Motley Fool
Why FLJ Group Shares Are Trading Higher By Around 96%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of FLJ Group Limited (NASDAQ: FLJ) shares jumped during Friday’s session after the company announced it entered into a definitive agreement to acquire Alpha Mind Technology. FLJ Group shares... 
Via Benzinga
Why Are U.S.-Traded Argentina Stocks Up Today?
Argentina has elected far-right libertarian Javier Milei as its President. Here's why this will likely be bad news for Argentina stocks. 
Via InvestorPlace
Milei's Election Win Fuels Major Gains in Argentine ADRs, ETFs: 'There Is No Free Lunch,' Analysts Say
Javier Milei‘s victory in Argentina’s presidential election sparked a rally in Argentine ADRs trading on major U.S. stock exchanges. 
Via Benzinga
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates... 
Via Benzinga
Dow Falls Over 100 Points; Hoth Therapeutics Shares Spike Higher
U.S. stocks traded mixed toward the end of trading, with Dow Jones dropping over 100 points on Tuesday. The Dow traded down 0.36% to 33,440.78 while the NASDAQ rose 0.09% to 13,241.04. The S&P 500,... 
Via Benzinga
10 Financials Stocks With Whale Alerts In Today's Session
Via Benzinga
Top 5 Financial Stocks That May Collapse
The most overbought stocks in the financial sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's trading, 50 companies set new 52-week lows. 
Via Benzinga
9 Financials Stocks Moving In Monday's After-Market Session
Gainers Merchants Bancorp (NASDAQ:MBIN) s... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
During Monday's session, 77 companies made new 52-week lows. 
Via Benzinga
45 Stocks Moving In Monday's Mid-Day Session
Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022
Upgrades UBS upgraded the previous rating for Align Technology Inc (NASDAQ:ALGN) from Neutral to Buy. For the third quarter, Align Tech had an EPS of $2.87, compared to year-ago... 
Via Benzinga
72 Biggest Movers From Yesterday
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.